Market Value226,505,046
Total Holdings37
File Date2025-05-05
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BSX / Boston Scientific Corporation
RVMD / Revolution Medicines, Inc.
NBIX / Neurocrine Biosciences, Inc.
PHVS / Pharvaris N.V.
ITCI / Intra-Cellular Therapies, Inc.
MRSN / Mersana Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
TMO / Thermo Fisher Scientific Inc.
GILD / Gilead Sciences, Inc.
AMGN / Amgen Inc.
JANX / Janux Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
SMMT / Summit Therapeutics Inc.
MIRM / Mirum Pharmaceuticals, Inc.
UNH / UnitedHealth Group Incorporated
ALKS / Alkermes plc
CRBP / Corbus Pharmaceuticals Holdings, Inc.
LLY / Eli Lilly and Company
MRK / Merck & Co., Inc.
ISRG / Intuitive Surgical, Inc.
COR / Cencora, Inc.
CAH / Cardinal Health, Inc.
DXCM / DexCom, Inc.
SYK / Stryker Corporation
HRMY / Harmony Biosciences Holdings, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
NAMS / NewAmsterdam Pharma Company N.V.
ABBV / AbbVie Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
BBIO / BridgeBio Pharma, Inc.
ACLX / Arcellx, Inc.
MRUS / Merus N.V.
EW / Edwards Lifesciences Corporation
UFPT / UFP Technologies, Inc.
KRYS / Krystal Biotech, Inc.
CABA / Cabaletta Bio, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
BCAX / Bicara Therapeutics Inc.
IRTC / iRhythm Technologies, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)